Arkolith/Insider Trading/NBP/Form 4

Dennis Phillip Andrew

Chief Medical OfficerNovaBridge Biosciences (NBP) · full profile →Form 4 · filed Jun 22, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$6K
Net Open-Market Flow
-$6K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 18, 2026Sell(S)8K$0.66$6K158K
Jun 17, 2026Option exercise(M)24K——166K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 17, 2026Option exercise(M)10K—$082K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0002089237-26-000006) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML